ResMed, Inc. (RMD)
251.43
+4.91
(+1.99%)
USD |
NYSE |
Dec 10, 16:00
251.43
0.00 (0.00%)
After-Hours: 18:42
ResMed Research and Development Expense (TTM): 339.08M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp. | 1.943B |
| Abbott Laboratories | 2.897B |
| Becton, Dickinson & Co. | 1.264B |
| Insulet Corp. | 270.80M |
| West Pharmaceutical Services, Inc. | 71.00M |